Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cardiac hypertrophy
ADR ID BADD_A00780
ADR Hierarchy
02      Cardiac disorders
02.04      Myocardial disorders
02.04.02      Myocardial disorders NEC
02.04.02.017      Cardiac hypertrophy
Description Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. | Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. [MeSH]
MedDRA Code 10007572
MeSH ID D006332
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cardiac hypertrophy | Myocardial hypertrophy | Cardiomegaly | Heart Enlargement | Enlargement, Heart | Enlarged Heart | Heart, Enlarged | Cardiac Hypertrophy | Heart Hypertrophy
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00142Anastrozole0.000159%
BADD_D00195Azathioprine0.000313%
BADD_D00367Carfilzomib0.000112%
BADD_D00531Corticotropin--
BADD_D00534Cosyntropin--
BADD_D00623Dexamethasone0.000145%
BADD_D00858Everolimus0.000229%
BADD_D01103Hydroxychloroquine0.006508%
BADD_D01304Lithium cation0.000192%
BADD_D01401Metformin0.000005%
BADD_D01645Oxycodone0.000021%
BADD_D01687Pazopanib0.000112%
BADD_D01831Prednisolone0.000035%
BADD_D01834Prednisone0.000022%
BADD_D01954Rivaroxaban0.000063%
BADD_D01970Rosiglitazone maleate--
BADD_D02105Tacrolimus--
BADD_D02107Tafamidis0.001077%
The 1th Page    1    Total 1 Pages